Paroxetine Tablet, Film Coated, Extended Release
Product Images NDC 62332-766

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 62332-766). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Tablets (Paroxetine 25)

Paroxetine Extended-Release Tablets, USP 25 mg label for a film-coated, extended-release oral tablet. The label indicates the product is manufactured by Alembic Pharmaceuticals Limited, formulated in Gujarat, India, and distributed by Alembic Pharmaceuticals, Inc. It includes storage instructions, dosing information, and a barcode. The package contains 30 tablets and is marked for pharmacist dispensing with a medication guide.*

FDA Label Image

30 Tablets (Paroxetine 37 5)

Paroxetine Extended-Release Tablets, USP 37.5 mg film-coated tablets in a 30 tablet package by Alembic Pharmaceuticals Inc. The label includes dosage storage instructions, manufacturer details (Alembic Pharmaceuticals Limited, India; Alembic Pharmaceuticals, Inc., USA), and a barcode with NDC 62332-768-30. It also notes the product is Rx only and advises dispensing the Medication Guide with each patient.*

FDA Label Image

Paroxetine-fig1.jpg (Paroxetine Fig1)

A chart displaying fold change and 90% confidence intervals for various drugs interacting with paroxetine. The graph plots change relative to reference on a logarithmic scale, showing Cmax and AUC values for Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg.*

FDA Label Image

Paroxetine-fig2.jpg (Paroxetine Fig2)

A chart illustrating fold changes and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of Paroxetine when coadministered with five different interacting drugs: Cimetidine, Phenobarbital, Phenytoin, Digoxin, and Diazepam. The x-axis represents change relative to reference, ranging from 0 to 2.*

FDA Label Image

Paroxetine-fig3.jpg (Paroxetine Fig3)

A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) in various population groups relative to a reference. Groups include renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years with different dosages, and gender (males). The x-axis depicts change relative to reference on a logarithmic scale.*

FDA Label Image

Paroxetine-str.jpg (Paroxetine Str)

Chemical structure of paroxetine hydrochloride, showing the molecular framework including a fluorophenyl group, a piperidine ring, and methylenedioxy substitution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.